Denitsa Milanova
President bij Marble Therapeutics, Inc.
Profiel
Denitsa M.
Milanova is an Independent Non-Executive Director at InSilico Medicine Cayman TopCo and holds the positions of President, Treasurer, Director & Vice President at Marble Therapeutics, Inc. She received her doctorate degree from Stanford University in 2016 and her undergraduate degree from the University of Central Florida in 2008.
Actieve functies van Denitsa Milanova
| Bedrijven | Functie | Begin |
|---|---|---|
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Directeur/Bestuurslid | 01-06-2023 |
Marble Therapeutics, Inc.
 Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA. | President | - |
Opleiding van Denitsa Milanova
| University of Central Florida | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
Marble Therapeutics, Inc.
Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA. | Commercial Services |
